close
close

Gottagopestcontrol

Trusted News & Timely Insights

    • Biotechnology and Pharmaceuticals

    FDA approves Bristol Myers Squibb’s schizophrenia drug
    Enterprise

    FDA approves Bristol Myers Squibb’s schizophrenia drug

    Cobenfy drug from Bristol Myers Squibb Courtesy: Bristol Myers Squibb The Food and Drug Administration gave approval Thursday Bristol Myers SquibbCobenfy, the highly anticipated schizophrenia drug, is the first novel treatment for the debilitating, chronic mental disorder in more than…

    Posted on Idris Bevan
    billion in cost reductions, 10 product launches planned
    Enterprise

    $1 billion in cost reductions, 10 product launches planned

    Exterior view of Moderna headquarters, Cambridge, Massachusetts, USA. Plexi images | Universal Images Group | Getty Images Moderna announced on Thursday that the company plans to cut spending by about $1.1 billion by 2027 and seek approvals for several new…

    Posted on Idris Bevan

    ads